Cargando…
Antinociceptive activity of the S1P-receptor agonist FTY720
FTY720 is a novel immunosuppressive drug that inhibits the egress of lymphocytes from secondary lymphoid tissues and thymus. In its phosphorylated form FTY720 is a potent S1P receptor agonist. Recently it was also shown that FTY720 can reduce prostaglandin synthesis through the direct inhibition of...
Autores principales: | Coste, Ovidiu, Pierre, Sandra, Marian, Claudiu, Brenneis, Christian, Angioni, Carlo, Schmidt, Helmut, Popp, Laura, Geisslinger, Gerd, Scholich, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401143/ https://www.ncbi.nlm.nih.gov/pubmed/18494940 http://dx.doi.org/10.1111/j.1582-4934.2008.00160.x |
Ejemplares similares
-
Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice
por: Brenneis, Christian, et al.
Publicado: (2008) -
FTY720-derivatives do not induce FTY720-like lymphopenia
por: Segura-Ulate, Ismael, et al.
Publicado: (2017) -
FTY720 attenuates excitotoxicity and neuroinflammation
por: Cipriani, Raffaela, et al.
Publicado: (2015) -
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
por: Alshaker, Heba, et al.
Publicado: (2017) -
Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation
por: Brenneis, Christian, et al.
Publicado: (2011)